Status:

COMPLETED

Role of Sleep Apnea and Sympathetic Activity in Resistant Hypertensive Patients.

Lead Sponsor:

Ottawa Hospital Research Institute

Conditions:

Type 2 Diabetes

Diabetic Nephropathy

Eligibility:

All Genders

18+ years

Phase:

PHASE3

Brief Summary

Hypertension is highly prevalent in type 2 diabetic patients (NIDDM) with nephropathy, and is the single most important determinant of the rate of renal function loss. In many of these patients, hyper...

Detailed Description

The study will be double blind and consist of two parallel groups. Patients with type 2 diabetes with a creatinine clearance above 20 ml/min and with microalbuminuria or proteinuria who have both resi...

Eligibility Criteria

Inclusion

  • .
  • Males and females 18 years or older
  • On 3 or more antihypertensive medications with resistant hypertension of \>140/90 mmHg (resting) despite treatment
  • Diagnosis of sleep apnea (15 apneic/hypopneic episodes per hour and a score of 10 on Epworth sleepiness scale).
  • Creatinine clearance \> 20 ml/min with microalbuminuria or proteinuria, (results within past 6 months)

Exclusion

  • Acute coronary syndrome within 6 months
  • Patients with clinically documented congestive heart failure
  • Patients with relevant cardiac arrhythmias (second and third-degree heart block or premature ventricular complexes in Lown classes IV or V)
  • Pregnant or lactating women
  • Patients with leg injury involving nerve damage
  • Patients with symptomatic peripheral neuropathy
  • Patients with predominant central sleep apnea
  • Patients mentally unable to give informed consent
  • Professional drivers
  • Patients with a resting blood pressure \>180/110 mmHg
  • Patients taking clonidine
  • Patients with sleep apnea causing daily drowsiness
  • Patients with severe hyperkalemia (\>5.5 mmol/L) or hypokalemia (\<3.3 mmol/L)
  • Patients with a BMI of \>35

Key Trial Info

Start Date :

December 1 2004

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

February 1 2015

Estimated Enrollment :

16 Patients enrolled

Trial Details

Trial ID

NCT01875341

Start Date

December 1 2004

End Date

February 1 2015

Last Update

February 10 2015

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

The Ottawa Hospital

Ottawa, Ontario, Canada, K1H 7W9